ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentGenevaiOnctura SA
iOnctura SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of iOnctura is the development of cancer drugs, particularly in oncology immunotherapy, with a focus on solid tumors, uveal melanoma and other types of cancer.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

iOnctura SA

✓ Offered6
Oncology small-molecule development
Oncology small-molecule programs against hard-to-treat, often neglected cancer types; focus on precisely targeted, orally dosed therapeutics with low toxicity.
Roginolisib (IOA-244)
Orally dosed PI3Kδ inhibitor in clinical development for uveal melanoma, NSCLC, myelofibrosis, CLL and PTCL; studied as monotherapy and in combination.
Cambritaxestat (IOA-289)
Orally dosed autotaxin inhibitor in clinical development for pancreatic and liver malignancies; studied in combination with chemotherapy.
IOA-359
Small molecule as a TGF-β signalling pathway inhibitor in development for solid tumors; designed for combination therapies against tumor resistance.
Clinical trials in oncology
Clinical trials in uveal melanoma, pancreatic cancer, NSCLC, myelofibrosis, CLL and PTCL with safety, efficacy and biomarker endpoints.
Precision oncology research
Research on first-in-class mechanisms at the tumor–stroma–immune interface; development of data-driven combination therapies against resistance mechanisms.
Trust & reputation

ranQ Trust Score of iOnctura SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

iOnctura SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
iOnctura SA scores 85.0 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
iOnctura SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
iOnctura SA scores 58.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.77.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.40.04%
Qualifications+0.00

iOnctura SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

October 22, 2025Media
Promising results in oncology research
startupticker.ch
July 3, 2025Media
Startups and support organisations strengethen their leadership
startupticker.ch
July 14, 2020Media
iOnctura extends series A round to €20 million
startupticker.ch

Knowledge

No knowledge articles yet

Once iOnctura SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

iOnctura SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank iOnctura SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of iOnctura SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Avenue de Sécheron 15
1202 Geneva

At a glance

Legal form
Corporation
UID
CHE-160.748.717
Founded
2017 · 9 years
Last commercial register change
March 19, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    DF
    Drugs for Neglected Diseases initiative (DNDi)
    Geneva
    FE
    Fondation EspeRare
    Geneva
    FP
    Fondation pour l'institut de hautes études internationales et du développement
    Geneva
    DS
    Dandelion Science Sàrl
    Geneva
    DA
    Davos Alzheimer's Collaborative (Genève)
    Geneva
    DP
    DRK Pharma Solutions SÀRL
    Vandoeuvres
    FC
    Fondation CanSearCH
    Geneva
    TI
    Triskel INTEGRATED SERVICES SA
    Le Grand-Saconnex